Systemic Pharmacokinetics of Everolimus Eluted From the Absorb Bioresorbable Vascular Scaffold: An ABSORB III Substudy

J Am Coll Cardiol. 2015 Dec 1;66(21):2467-2469. doi: 10.1016/j.jacc.2015.09.030. Epub 2015 Oct 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Absorbable Implants*
  • Aged
  • Drug-Eluting Stents*
  • Everolimus / administration & dosage
  • Everolimus / pharmacokinetics*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Tissue Scaffolds*

Substances

  • Everolimus